In doing so, they observed that a subtype of cardiac macrophages was characterized by IRF3/type I IFN activation, and that disruption of either IRF3 or IFNAR signaling resulted in improved survival following MI, decreased inflammation and improved cardiac function (37). The gene discussed is IRF3; the disease is myocardial infarction.